Cargando…
Dalbavancin: a novel antimicrobial
The increasing incidence of serious infections because of Gram-positive pathogens and the rising cost in parenteral administration of antimicrobials has inspired the development of a novel antibiotic. Dalbavancin is the first once a week antibiotic with activity against a broad range of Gram-positiv...
Autores principales: | Chen, A Y, Zervos, M J, Vazquez, J A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1890846/ https://www.ncbi.nlm.nih.gov/pubmed/17362476 http://dx.doi.org/10.1111/j.1742-1241.2007.01318.x |
Ejemplares similares
-
Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer’s disease: a review
por: Kurz, A, et al.
Publicado: (2009) -
Pharmacology of Ramelteon, a Selective MT(1)/MT(2) Receptor Agonist: A Novel Therapeutic Drug for Sleep Disorders
por: Miyamoto, Masaomi
Publicado: (2009) -
Ivabradine – the first selective sinus node I(f) channel inhibitor in the treatment of stable angina
por: Sulfi, S, et al.
Publicado: (2006) -
Tolerability and safety of fluvoxamine and other antidepressants
por: Westenberg, HGM, et al.
Publicado: (2006) -
Dalbavancin
por: Barberán, José, et al.
Publicado: (2021)